These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 31851779)
1. PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cells. Ge L; Wang H; Xu X; Zhou Z; He J; Peng W; Du F; Zhang Y; Gong A; Xu M J Cell Mol Med; 2020 Jan; 24(2):1969-1979. PubMed ID: 31851779 [TBL] [Abstract][Full Text] [Related]
2. PRMT5 regulates colorectal cancer cell growth and EMT via EGFR/Akt/GSK3β signaling cascades. Yan Y; Zhao P; Wang Z; Liu Z; Wang Z; Zhang J; Ding Y; Hua X; Yu L Aging (Albany NY); 2021 Jan; 13(3):4468-4481. PubMed ID: 33495409 [TBL] [Abstract][Full Text] [Related]
3. Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling. Chung J; Karkhanis V; Baiocchi RA; Sif S J Biol Chem; 2019 May; 294(19):7692-7710. PubMed ID: 30885941 [TBL] [Abstract][Full Text] [Related]
4. PRMT5 Promotes EMT Through Regulating Akt Activity in Human Lung Cancer. Huang J; Zheng Y; Zheng X; Qian B; Yin Q; Lu J; Lei H Cell Transplant; 2021; 30():9636897211001772. PubMed ID: 33829865 [TBL] [Abstract][Full Text] [Related]
5. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2. Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517 [TBL] [Abstract][Full Text] [Related]
6. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling. Hu W; Wang Z; Zhang S; Lu X; Wu J; Yu K; Ji A; Lu W; Wang Z; Wu J; Jiang C Sci Rep; 2019 May; 9(1):7539. PubMed ID: 31101875 [TBL] [Abstract][Full Text] [Related]
7. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway. Douchi D; Ohtsuka H; Ariake K; Masuda K; Kawasaki S; Kawaguchi K; Fukase K; Oikawa M; Motoi F; Naitoh T; Katayose Y; Egawa S; Unno M Cancer Lett; 2015 Aug; 365(1):132-40. PubMed ID: 26047573 [TBL] [Abstract][Full Text] [Related]
8. PRMT5/FGFR3/AKT Signaling Axis Facilitates Lung Cancer Cell Metastasis. Zheng Y; Lu J; Hu X; Hu X; Gao X; Zhou J Technol Cancer Res Treat; 2023; 22():15330338231161139. PubMed ID: 36927233 [No Abstract] [Full Text] [Related]
9. Vimentin loss promotes cancer proliferation through up-regulating Rictor/AKT/β-catenin signaling pathway. Ding Y; Lv C; Zhou Y; Zhang H; Zhao L; Xu Y; Fan X Exp Cell Res; 2021 Aug; 405(1):112666. PubMed ID: 34052237 [TBL] [Abstract][Full Text] [Related]
10. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR. Li L; Zhang S; Li H; Chou H BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201 [TBL] [Abstract][Full Text] [Related]
11. Protein arginine methyltransferase 1 coordinates the epithelial-mesenchymal transition/proliferation dichotomy in gastric cancer cells. Zhang Y; Wang D; Zhang M; Wei H; Lu Y; Sun Y; Zhou M; Gu S; Feng W; Wang H; Zeng J; Gong A; Xu M Exp Cell Res; 2018 Jan; 362(1):43-50. PubMed ID: 29097184 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer. Zhou X; Hu Y; Dai L; Wang Y; Zhou J; Wang W; Di W; Qiu L PLoS One; 2014; 9(5):e96718. PubMed ID: 24816687 [TBL] [Abstract][Full Text] [Related]
13. Metadherin-PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT-β-catenin signaling pathway. Zhu K; Peng Y; Hu J; Zhan H; Yang L; Gao Q; Jia H; Luo R; Dai Z; Tang Z; Fan J; Zhou J Carcinogenesis; 2020 Apr; 41(2):130-138. PubMed ID: 31498866 [TBL] [Abstract][Full Text] [Related]
14. p21-Activated kinase 3 promotes cancer stem cell phenotypes through activating the Akt-GSK3β-β-catenin signaling pathway in pancreatic cancer cells. Wu HY; Yang MC; Ding LY; Chen CS; Chu PC Cancer Lett; 2019 Aug; 456():13-22. PubMed ID: 31051214 [TBL] [Abstract][Full Text] [Related]
15. Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis. Gao F; Alwhaibi A; Sabbineni H; Verma A; Eldahshan W; Somanath PR Cancer Lett; 2017 Aug; 402():177-189. PubMed ID: 28602980 [TBL] [Abstract][Full Text] [Related]
16. ERas regulates cell proliferation and epithelial-mesenchymal transition by affecting Erk/Akt signaling pathway in pancreatic cancer. Liu Y; Qin P; Wu R; Du L; Li F Hum Cell; 2020 Oct; 33(4):1186-1196. PubMed ID: 32700262 [TBL] [Abstract][Full Text] [Related]
17. PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis. Qin Y; Hu Q; Xu J; Ji S; Dai W; Liu W; Xu W; Sun Q; Zhang Z; Ni Q; Zhang B; Yu X; Xu X Cell Commun Signal; 2019 Mar; 17(1):30. PubMed ID: 30922330 [TBL] [Abstract][Full Text] [Related]
18. α-Mangostin suppresses the viability and epithelial-mesenchymal transition of pancreatic cancer cells by downregulating the PI3K/Akt pathway. Xu Q; Ma J; Lei J; Duan W; Sheng L; Chen X; Hu A; Wang Z; Wu Z; Wu E; Ma Q; Li X Biomed Res Int; 2014; 2014():546353. PubMed ID: 24812621 [TBL] [Abstract][Full Text] [Related]
19. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer. Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915 [TBL] [Abstract][Full Text] [Related]
20. FGF18 Enhances Migration and the Epithelial-Mesenchymal Transition in Breast Cancer by Regulating Akt/GSK3β/Β-Catenin Signaling. Song N; Zhong J; Hu Q; Gu T; Yang B; Zhang J; Yu J; Ma X; Chen Q; Qi J; Liu Y; Su W; Feng Z; Wang X; Wang H Cell Physiol Biochem; 2018; 49(3):1019-1032. PubMed ID: 30196303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]